Chemoinformaics analysis of 7-HYDROXY-4-(3-HYDROXY-4-METHOXYPHENYL)-5-METHOXYCHROMEN-2-ONE
| Molecular Weight | 314.293 | nRot | 3 |
| Heavy Atom Molecular Weight | 300.181 | nRig | 18 |
| Exact Molecular Weight | 314.079 | nRing | 3 |
| Solubility: LogS | -3.585 | nHRing | 1 |
| Solubility: LogP | 2.587 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 42.5371 |
| nHD | 2 | BPOL | 20.1209 |
| QED | 0.723 |
| Synth | 2.306 |
| Natural Product Likeliness | 0.995 |
| NR-PPAR-gamma | 0.936 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.988 |
| HIA | 0.018 |
| CACO-2 | -4.809 |
| MDCK | 0.0000166 |
| BBB | 0.03 |
| PPB | 0.936332 |
| VDSS | 0.749 |
| FU | 0.092092 |
| CYP1A2-inh | 0.966 |
| CYP1A2-sub | 0.958 |
| CYP2c19-inh | 0.663 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.559 |
| CYP2c9-sub | 0.925 |
| CYP2d6-inh | 0.778 |
| CYP2d6-sub | 0.918 |
| CYP3a4-inh | 0.831 |
| CYP3a4-sub | 0.24 |
| CL | 11.93 |
| T12 | 0.863 |
| hERG | 0.094 |
| Ames | 0.307 |
| ROA | 0.038 |
| SkinSen | 0.594 |
| Carcinogencity | 0.042 |
| EI | 0.917 |
| Respiratory | 0.347 |
| NR-Aromatase | 0.718 |
| Antiviral | Yes |
| Prediction | 0.787448 |